# A Study Comparing Two Ferric Carboxymaltose Formulations in Patients With Iron Deficiency Anemia

> **NCT03399084** · PHASE1 · COMPLETED · sponsor: **Sandoz** · enrollment: 71 (actual)

## Conditions studied

- Iron Deficiency Anemia

## Interventions

- **DRUG:** Ferric carboxymaltose

## Key facts

- **NCT ID:** NCT03399084
- **Lead sponsor:** Sandoz
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-29
- **Primary completion:** 2019-01-15
- **Final completion:** 2019-01-15
- **Target enrollment:** 71 (ACTUAL)
- **Last updated:** 2019-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03399084

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03399084, "A Study Comparing Two Ferric Carboxymaltose Formulations in Patients With Iron Deficiency Anemia". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03399084. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*